13F Pro13F Pro

Knoll Capital Management, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1325083
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare40.3%$72.3M
  • Materials32.9%$58.9M
  • Financials21.0%$37.6M
  • Technology3.8%$6.8M
  • Other1.1%$1.9M
  • Consumer Staples1.0%$1.8M

AUM History

13fpro.ai/research/fund/knoll-capital-management-llc-1325083

Conviction and streaks

Stable · top 10 = 58.8%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/knoll-capital-management-llc-1325083

Knoll Capital Management, LLC 13F holdings — Q2 2026

$179.3M portfolio (-5.0% QoQ) · 37 holdings · Q2 2026 13F · top 10 are 59% of the stock portfolio

All holdings — Knoll Capital Management, LLC (Q2 2026)

37 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
OR$OROR Royalties Inc.$7.1M—
SSRM$SSRMSSR MINING INC.$6.9M—
FNV$FNVFRANCO NEVADA Corp$6.7M—
BAH$BAHBooz Allen Hamilton Holding Corp$5.7M—
CGAU$CGAUCenterra Gold Inc.$5.7M—
ELTX$ELTXElicio Therapeutics, Inc.$4.7M+92%
ABVX$ABVXAbivax S.A.adr$4.7MNew
PAAS$PAASPAN AMERICAN SILVER CORP$4.5M—
PSLV$PSLVSprott Physical Silver Trust$4.2M—
TFPM$TFPMTriple Flag Precious Metals Corp.$3.4M—
ABEO$ABEOABEONA THERAPEUTICS INC.$3.0M—
GROY$GROYGold Royalty Corp.$2.8M—
NEWP$NEWPNEW PACIFIC METALS CORP$1.9M—
— iSHares US Aerospace & Defense - US AER DEF ETFetf/fund$1.9M—
PM$PMPhilip Morris International Inc.$1.8M—

What changed in Q2 2026

Against the previous quarter's 13F: 1 new, 4 added to, 0 trimmed, 1 sold out. Share-count changes; largest moves by dollar size first.

New positions (1)

  • ABVX$ABVXAbivax S.A.$4.7M

    first bought this quarter

Added to (4)

  • OCUL$OCULOCULAR THERAPEUTIX, INC+92%

    now $11.3M

  • ELTX$ELTXElicio Therapeutics, Inc.+92%

    now $4.7M

  • NUVB$NUVBNuvation Bio Inc.+7%

    now $9.1M

  • PHAR$PHARPharming Group N.V.+0.8%

    now $57K

Trimmed (0)

No positions trimmed this quarter.

Sold out (1)

  • CRDL$CRDLCardiol Therapeutics Inc.was $135K

    held 8 qtrs

Holdings by quarter

Every 13F Knoll Capital Management, LLC has filed, 41 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Portfolio Overview

Knoll Capital Management, LLC disclosed 37 positions worth $179.3M in its Form 13F-HR for Q2 2026, led by $MGTX (MeiraGTx Holdings plc) at 9.4% of the equity portfolio, followed by $PHYS and $ALDX. During the quarter the fund opened 1 new position and exited 1 — including a new stake in $ABVX and a full exit from $CRDL. The portfolio is most concentrated in Healthcare (40.3% of disclosed assets). All figures are sourced directly from Knoll Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1325083.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Knoll Capital Management, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For Knoll Capital Management, LLC (SEC CIK: 1325083), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Knoll Capital Management, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.